Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
CyberKnife SBRT appears to be a promising treatment modality for managing primary pancreatic cancer with metastases to the gastrointestinal tract, with minimal adverse reactions.
Authors
- Ming Wei (ORCID: https://orcid.org/0000-0003-3134-0377)
- Zunhao Zhang (ORCID: https://orcid.org/0000-0002-2599-2611)
- Changwen Bo
- Hui Xu (ORCID: https://orcid.org/0000-0002-1908-7818)
- Xianwei Liang
- Huang He (ORCID: https://orcid.org/0000-0002-3885-6045)
- Bo Tian (ORCID: https://orcid.org/0000-0002-8936-6783)
- Yunfei Bian (ORCID: https://orcid.org/0000-0002-2699-0749)
- Zhao Zhitao
Institutions
- Hebei Medical University (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Cancer Management and Research
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/cmar.s526924
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00